Abstract
Apocrine hidradenocarcinoma appears as an asymptomatic subcutaneous nodule in any area of the body surface.
Histopathologically, apocrine hidradenocarcinoma is a multilobulated neoplasm, with solid aggregates of neoplastic cells that vary in shape and size and infiltrate the dermis.
Neoplastic cells of apocrine hidradenocarcinoma may be clear cells, pale cells, squamous cells, polygonal cells, oncocytoid cells, or mucinous cells, with variable proportions among these cells from case to case. Nuclear pleomorphism, mitotic figures, and the degree of atypia may be very striking. The stroma is composed of sclerotic collagen bundles.
Immunohistochemistry demonstrates positivity for CAM 5.2, AE1/AE3, CK5/CK6/CK7/CK19, EMA, CEA, S-100 protein, bcl-1, bcl-2, p63, androgen receptor, EGFR, estrogen receptor, MUC5AC, and p53 in neoplastic cells.
Apocrine hidradenocarcinoma is an aggressive neoplasm, and it should be excised with wide clear margins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Liu Y. The histogenesis of clear cell papillary carcinoma of the skin. Am J Pathol. 1949;25:93–103.
Kersting DW. Clear cell hidradenoma and hidradenocarcinoma. Arch Dermatol. 1963;87:323–33.
Mackenzie DH. A clear-cell hidradenocarcinoma with metastases. Cancer. 1957;10:1021–3.
Keasbey LE, Hadley CG. Clear-cell hidradenoma. Report of three cases with widespread metastases. Cancer. 1954;7:934–52.
Czrnecki DB, Aarons I, Dowling JP, Lauritz B, Wallis P, Taft EH. Malignant clear cell hidradenoma. A case report. Acta Derm Venereol. 1982;62:173–6.
Headington JT, Neiderhuber JE, Beals TF. Malignant clear cell acrospiroma. Cancer. 1978;44:641–7.
Ogilive JW. Malignant eccrine acrospiroma. J Bone Joint Surg. 1982;64A:780–2.
Gallager MS, Miller GV, Grampa G. Primary mucoepidermoid carcinoma of the skin. Report of a case. Cancer. 1959;12:286–8.
Wenig BL, Sciubba JJ, Goodman RS, Platt N. Primary cutaneous mucoepidermoid carcinoma of the anterior neck. Laryngoscope. 1983;93:464–7.
Hernández-Pérez E, Cestoni-Parducci R. Nodular hidradenoma and hidradenocarcinoma. A 10-year review. J Am Acad Dermatol. 1985;12:15–20.
Swanson PE, Cherwitz DL, Neumann MP, Wick MR. Eccrine sweat gland carcinoma: a histologic and immunohistochemical study of 32 cases. J Cutan Pathol. 1987;14:65–86.
Dissanayake RVP, Salm R. Sweat gland carcinomas: prognosis related to histological type. Histopathology. 1980;4:445–66.
Berg JW, McDivitt RW. Pathology of sweat gland carcinoma. Pathol Annu. 1968;3:123–44.
Stout AP, Cooley SGE. Carcinoma of sweat glands. Cancer. 1951;4:521–36.
Lever WF, Castleman B. Clear-cell myoepithelioma of the skin. Report of ten cases. Am J Pathol. 1952;28:691–9.
Santler VR, Eberhartinger C. Malignes Karzellen-Myoepitheliom. Dermatologica. 1965;130:340–7.
Johnson BL, Helwig EB. Eccrine acrospiroma. A clinicopathologic study. Cancer. 1969;23:641–57.
Chung CK, Hefferman AH. Clear cell hidradenoma with metastasis. Case report with a review of the literature. Plast Reconstr Surg. 1971;148:177–80.
Hunt SJ, Santa Cruz DJ, Kerl H. Giant eccrine acrospiroma. J Am Acad Dermatol. 1990;23:663–8.
Lim SC, Lee MJ, Lee MS, Kee KH, Suh CH. Giant hidradenocarcinoma: a report of malignant transformation from nodular hidradenoma. Pathol Int. 1998;48:818–23.
Park HJ, Kim YC, Cinn YW. Nodular hidradenocarcinoma with prominent squamous differentiation: case report and immunohistochemical study. J Cutan Pathol. 2000;27:423–7.
Herraiz Serrano C, Santos Gil I, Calderón Montero A, Suárez Fernández C. Acrospiroma maligno como causa de fiebre de origen desconocido. Med Clin (Barc). 1992;96:316.
Satoh T, Katsumata M, Tokura Y, Iwatsuki K, Takigawa M. Clear cell hidradenoma with whorl formation of squamoid cells: immunohistochemical and electron microscopic studies. J Am Acad Dermatol. 1989;21:271–7.
Kazakov DV, Ivan D, Kutzner H, et al. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19)translocation. Am J Dermatopathol. 2009;31:236–47.
Wong TY, Suster S, Nogita T, Duncan LM, Dickersin RG, Mihm Jr MC. Clear cell eccrine carcinomas of the skin. A clinicopathologic study of nine patients. Cancer. 1994;73:1631–43.
Wahl CE, Todd DH, Binder SW, Cassarino DS. Apocrine hidradenocarcinoma showing Paget’s disease and mucinous metaplasia. J Cutan Pathol. 2009;36:582–5.
Abenoza P, Ackerman AB. Hidradenomas. In: Neoplasms with eccrine differentiation. Philadelphia: Lea & Febiger; 1990:311–350.
Requena L. Kiryu H. Ackerman AB. Apocrine hidradenocarcinoma. In: Neoplasms with apocrine differentiation. Philadelphia: Lippincott-Raven; 1998:687–704.
Ko CJ, Cochran AJ, Eng W, Binder SW. Hidradenocarcinoma: a histological and immunohistochemical study. J Cutan Pathol. 2006;33:726–30.
Nash JW, Barrett TL, Kies M, Ross MI, Sneige N, Diwan AH, Lazar AJ. Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications. J Cutan Pathol. 2007;34:49–54.
Nazarian RM, Kapur P, Rakheja D, Piris A, Duncan LM, Mihm Jr MC, Hoang MP. Atypical and malignant hidradenomas: a histological and immunohistochemical study. Mod Pathol. 2009;22:600–10.
Biernat W, Peraud A, Wozniak L, Ohgaki H. p53 mutations in sweat gland carcinomas. Int J Cancer. 1998;76:317–20.
Piris A, Scopsi L, Clemente C, Cetti Serbelloni F, Mihm Jr MC, Hoang MP. Epidermal growth factor receptor gene status by fluorescence in situ hybridization in malignant, atypical, and benign hidradenomas. Am J Dermatopathol. 2010;32:586–92.
Souvatzidis P, Sbano P, Mandato F, Fimiani M, Castelli A. Malignant nodular hidradenoma of the skin: report of seven cases. J Eur Acad Dermatol Venereol. 2008;22:549–54.
Stefanato CM, Ferrara G, Chaudhry IH, Guevara Pineda C, Waschkowski G, Rose C, Calonje E. Clear cell nodular hidradenoma involving the lymphatic system: a tumor of uncertain malignant potential or a novel example of “metastasizing” benign tumor? Am J Surg Pathol. 2012;36:1835–40.
Lerner A, Beckford A, Ugent S, Goldberg L, Jalisi S, Demierre MF. Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatment. Arch Dermatol. 2011;147:998–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Requena, L., Sangüeza, O. (2017). Apocrine Hidradenocarcinoma. In: Cutaneous Adnexal Neoplasms. Springer, Cham. https://doi.org/10.1007/978-3-319-45704-8_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-45704-8_20
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45703-1
Online ISBN: 978-3-319-45704-8
eBook Packages: MedicineMedicine (R0)